Hyperhidrosis Treatment Market Size and Forecasts (2021 - 2031), Global and Regional Share, Trends, and Growth Opportunity Analysis

Coverage: Hyperhidrosis Treatment Market covers analysis by Treatment Type (Botulinum Toxin A, Iontophoresis, Surgical Treatments, Topical Treatments, Non-surgical Microwave Energy Destruction of Sweat Glands, Others); Hyperhidrosis Type (Axillary Hyperhidrosis, Palmar Hyperhidrosis, Plantar Hyperhidrosis, Others); End User (Hospitals, Ambulatory Surgical Centers, Others), and Geography (North America, Europe, Asia Pacific, and South and Central America)

  • Report Code : TIPRE00011961
  • Category : Pharmaceuticals
  • No. of Pages : 150
Buy Now

Hyperhidrosis Treatment Market Size and Forecasts (2021 - 2031), Global and Regional Share, Trends, and Growth Opportunity Analysis

Buy Now

MARKET INTRODUCTION

Hyperhidrosis is abnormally excessive sweating that's not necessarily related to heat or exercise. Hyperhidrosis is a condition that involves excessive sweating. It may affect the whole body or just specific areas. Besides disrupting normal daily activities, this type of heavy sweating can cause social anxiety and embarrassment.

MARKET DYNAMICS

The hyperhidrosis treatment market is driving due to the demand for non-surgical topical treatments, non-surgical microwave energy destruction of sweat glands, and botulinum toxin procedures is rising, owing to benefits such as minimum or no downtime, no wear and tear of skin surface, and minimal side effects. Moreover, the increasing prevalence of axillary hyperhidrosis has been triggering the demand for effective treatments, such as fractional microneedle radiofrequency (FMR) treatment, tap water iontophoresis, and microwave technology.

MARKET SCOPE

The "Hyperhidrosis Treatment Market Analysis to 2028" is a specialized and in-depth study of the pharmaceutical industry with a special focus on the global market trend analysis. The report aims to provide an overview of hyperhidrosis treatment market with detailed market segmentation by treatment type, hyperhidrosis type and end user. The hyperhidrosis treatment market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in hyperhidrosis treatment market and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The hyperhidrosis treatment market is segmented on the basis of treatment type, hyperhidrosis type and end user. Based on treatment type, the market is segmented as botulinum toxin A, iontophoresis, surgical treatments, topical treatments, non-surgical microwave energy destruction of sweat glands, and others. On the basis of hyperhidrosis type, the market is categorized as axillary hyperhidrosis, palmar hyperhidrosis, plantar hyperhidrosis, and others. On the basis of end user, the market is categorized as hospitals, ambulatory surgical centers, and others.

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the hyperhidrosis treatment market based on various segments. It also provides market size and forecast estimates from year 2020 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The hyperhidrosis treatment market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting hyperhidrosis treatment market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the hyperhidrosis treatment market in these regions.


Hyperhidrosis Treatment Market Report Analysis

Hyperhidrosis Treatment Market

  • CAGR (2023 - 2031)
    XX%
  • Market Size 2023
    US$ XX Million
  • Market Size 2031
    US$ XX Million

Report Coverage

  • Market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
  • Key future trends
  • Detailed PEST/Porter’s Five Forces and SWOT analysis
  • Industry landscape and competition analysis & recent developments
  • Detailed company profiles
  • Global and regional market analysis covering key market trends, major players, regulations, and recent market developments

Key Players

  • Allergan plc
  • GlaxoSmithKline plc
  • Miramar Labs, Inc.
  • Revance Therapeutics, Inc.
  • TheraVida, Dermira, Inc.
  • Ulthera, Inc.

Regional Overview

  • North America
  • Europe
  • Asia-Pacific
  • South and Central America
  • Middle East and Africa

Market Segmentation

By Treatment Type
  • Botulinum Toxin A
  • Iontophoresis
  • Surgical Treatments
  • Topical Treatments
  • Non-surgical Microwave Energy Destruction of Sweat Glands
  • Others
By Hyperhidrosis Type
  • Axillary Hyperhidrosis
  • Palmar Hyperhidrosis
  • Plantar Hyperhidrosis
  • Others
By End User
  • Hospitals
  • Ambulatory Surgical Centers
  • Others
  • Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
MARKET PLAYERS


The report covers key developments in the hyperhidrosis treatment market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from hyperhidrosis treatment market are anticipated to have lucrative growth opportunities in the future with the rising demand for hyperhidrosis treatment in the global market. Below mentioned is the list of few companies engaged in the hyperhidrosis treatment market.

The report also includes the profiles of key players in hyperhidrosis treatment market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.

  •   Allergan plc
  •   GlaxoSmithKline plc
  •   Miramar Labs, Inc.
  •   Revance Therapeutics, Inc.
  •   TheraVida, Dermira, Inc.
  •   Ulthera, Inc.


The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.

Hyperhidrosis Treatment Market Report Scope

Report Attribute Details
Market size in 2023 US$ XX Million
Market Size by 2031 US$ XX Million
Global CAGR (2023 - 2031) XX%
Historical Data 2021-2022
Forecast period 2024-2031
Segments Covered By Treatment Type
  • Botulinum Toxin A
  • Iontophoresis
  • Surgical Treatments
  • Topical Treatments
  • Non-surgical Microwave Energy Destruction of Sweat Glands
  • Others
By Hyperhidrosis Type
  • Axillary Hyperhidrosis
  • Palmar Hyperhidrosis
  • Plantar Hyperhidrosis
  • Others
By End User
  • Hospitals
  • Ambulatory Surgical Centers
  • Others
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • Allergan plc
  • GlaxoSmithKline plc
  • Miramar Labs, Inc.
  • Revance Therapeutics, Inc.
  • TheraVida, Dermira, Inc.
  • Ulthera, Inc.
    • Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
    Report Coverage
    Report Coverage

    Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

    Segment Covered
    Segment Covered

    This text is related
    to segments covered.

    Regional Scope
    Regional Scope

    North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

    Country Scope
    Country Scope

    This text is related
    to country scope.

    The List of Companies

    1. Allergan plc
    2. GlaxoSmithKline plc
    3. Miramar Labs, Inc.
    4. Revance Therapeutics, Inc.
    5. TheraVida, Dermira, Inc.
    6. Ulthera, Inc.

    Trends and growth analysis reports related to Pharmaceuticals : READ MORE..